Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence study of cetylpyridinium chloride + benzydamine for sore throat
2013-002970-32Phase 3Completed
- Sponsor
- Krka
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of benzydamine + cetylpyridine chloride and benzydamine in upper respiratory infection (URI) (3 arms), sponsored by Krka. Primary endpoint: Sore throat pain intensity difference at 1 hour. Started Nov 2013; status: completed.
02
Drugs
benzydamine + cetylpyridine chloridebenzydamine
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on 2013-002970-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002970-32.